Affinor Resources (C.AFI) ups brain trust with vertical farming pioneer appointment

Gaalen Engen Gaalen Engen, Stockhouse.com
2 Comments| April 10, 2014


Affinor Resources (CSE:C.AFI, Stock Forum), a Montreal Quebec-based recent entrant in the emerging medical marijuana sector, has been on a mission over the last two weeks to add to the company’s collective brain power and MMJ experience as it positions itself to operate within the medical marijuana sector, culminating with the appointment of vertical farming pioneer, Greg Dennison.
 
Since announcing its entry into the “dot bong” race at the end of March, the company has made a series of strategic appointments to both its executive and advisory board in an effort to bolster its position within the newly minted sector.
 
With drug development expert, Sazzad Hossain PhD, and plant molecular biologist, Dr. Hyder A. Khoja already on its advisory board; and Agri-Products development expert Tegan Adams acting as COO, the company now adds once again to its intellectual powerhouse with the appointment of Mr. Dennison.
 
Mr. Dennison, 30-year construction industry veteran and president of Advanced Vertical Farming, holds the VDL license for Alberta with the aim to pioneer the mass production of vertically grown, fresh and pesticide-free produce.
 
According to the news release, Mr. Dennison is to receive 100,000 incentive stock options in Affinor exercisable on or before April 9, 2019 at $0.25 per share.
 
As a result of Mr. Dennison’s appointment, Martin Nicoletti will step down as CFO effective immediately but Mr. Nicoletti will continue to remain the internal accountant and Affinor board member.
 
Company president and CEO, Sebastien Plouffe, commented on the appointment, “We are extremely pleased to have Greg as the new CFO of the company as he's adding lots of credibility, integrity, experience and knowledge to our existing team and will be very helpful to achieve our goals and key to build the company at the level we are aspiring.”
 
Affinor Resources was in the news recently when the company announced Dr. Khoja’s advisory appointment.
 
Currently there are 35.4m outstanding shares with a market cap of $16.3 million.


Rate this article
0 stars
v
Usefulness

Clarity

Credibility